|
Multiple sclerosis
Citations 401-410 of 475 total displayed.
|
Past content
(since Jan 2001):
|
- ARTICLES
Acute disseminated encephalomyelitis: A long-term follow-up study of 84 pediatric patients
- Silvia Tenembaum, Nestor Chamoles, and Natalio Fejerman
Neurology 2002; 59: 1224-1231.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Copaxone’s effect on MRI-monitored disease in relapsing MS is reproducible and sustained
- J.S. Wolinsky, G. Comi, M. Filippi, D. Ladkani, S. Kadosh, and G. Shifroni
Neurology 2002; 59: 1284-1286.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MS
- Scott S. Zamvil and Lawrence Steinman
Neurology 2002; 59: 970-971.
[Full text]
[PDF]
- ARTICLES
Statins as immunomodulators: Comparison with interferon-ß1b in MS
- O. Neuhaus, S. Strasser-Fuchs, F. Fazekas, B.C. Kieseier, G. Niederwieser, H.P. Hartung, and J.J. Archelos
Neurology 2002; 59: 990-997.
[Abstract]
[Full text]
[PDF]
- ARTICLES
MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group
- CHAMPS Study Group
Neurology 2002; 59: 998-1005.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Early onset multiple sclerosis: A longitudinal study
- A. Boiko, G. Vorobeychik, D. Paty, V. Devonshire, D. Sadovnick, and the UBC MS Clinic Neurologists
Neurology 2002; 59: 1006-1010.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Multiple sclerosis–associated retrovirus and MS prognosis: An observational study
- S. Sotgiu, C. Serra, G. Mameli, M. Pugliatti, G. Rosati, G. Arru, and A. Dolei
Neurology 2002; 59: 1071-1073.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange
- Yang Mao-Draayer, Steven Braff, William Pendlebury, and Hillel Panitch
Neurology 2002; 59: 1074-1077.
[Abstract]
[Full text]
[PDF]
- VIEWS & REVIEWS
Differential mechanisms of action of interferon-ß and glatiramer acetate in MS
- V. Wee Yong
Neurology 2002; 59: 802-808.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS
- R. G. Ghalie, G. Edan, M. Laurent, E. Mauch, S. Eisenman, H. P. Hartung, R. E. Gonsette, M. D. Butine, and D. E. Goodkin
Neurology 2002; 59: 909-913.
[Abstract]
[Full text]
[PDF]
|
|
